---
title: "Bambusa Therapeutics tumbles 12% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303796258.md"
description: "Bambusa Therapeutics fell 11.56% to US$14.15. The intraday swing reached 10.62%."
datetime: "2026-10-30T19:27:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303796258.md)
  - [en](https://longbridge.com/en/news/303796258.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303796258.md)
generator: "portal-rs"
---

# Bambusa Therapeutics tumbles 12% during regular trading

Bambusa Therapeutics (BBTX.US) tumbled nearly **12%** during regular trading to **$14.15**.

The intraday swing reached 10.62%.

The Nasdaq Composite is down 2.41% over the past five sessions and up 8.98% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [BBTX.US](https://longbridge.com/en/quote/BBTX.US.md)

## Related News & Research

- [Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition](https://longbridge.com/en/news/304008064.md)
- [Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics](https://longbridge.com/en/news/304691682.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Marvell outlines custom HBM design approach at 2026 OCP Global Summit](https://longbridge.com/en/news/305857411.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**